Answer
Following an oral dose, the median effective plasma half-lives of roflumilast and its N-oxide metabolite are approximately 17 hours and 30 hours, respectively.
Sources for this answer
- DAXAS 500 micrograms film-coated tabletsAstraZeneca UK Limited · emc · SmPC §5.2 Pharmacokinetic properties · Version 16Document updated
Sources checked